ILYPSA
It discovers and develops renal care pharmaceutical products. It develops non-absorbed polymeric phosphate and potassium binder compounds to treat chronic kidney diseases. The company, formerly known as Symyx Therapeutics, Inc. was founded in 2002 and is based in Santa Clara, California.
ILYPSA
Industry:
Biotechnology Manufacturing Medical
Founded:
2002-01-01
Address:
Santa Clara, California, United States
Country:
United States
Website Url:
http://www.ilypsa.com
Total Employee:
10001+
Status:
Active
Contact:
408-215-2800
Email Addresses:
[email protected]
Total Funding:
44 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Nginx Baidu Analytics Psychz Networks 22.cn
Founder
Investors List
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series B - Ilypsa
Delphi Ventures
Delphi Ventures investment in Series B - Ilypsa
U.S. Venture Partners
U.S. Venture Partners investment in Series B - Ilypsa
Sprout Group
Sprout Group investment in Series A - Ilypsa
5AM Ventures
5AM Ventures investment in Series A - Ilypsa
Official Site Inspections
http://www.ilypsa.com Semrush global rank: 5.21 M Semrush visits lastest month: 1.56 K
- Host name: 240-229-197-91.ldn.kgix.net
- IP address: 91.197.229.240
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Ilypsa"
Ilypsa - Crunchbase Company Profile & Funding
Ilypsa is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.See details»
Ilypsa, Inc. Company Profile | Santa Clara, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Ilypsa, Inc. of Santa Clara, CA. Get the latest business insights from Dun & Bradstreet.See details»
Ilypsa - Products, Competitors, Financials, Employees, …
Headquarters Location. 3406 Central Expressway . Santa Clara, California, 95051, United States. 408-215-2800See details»
Ilypsa, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
This organization specializes in creating pharmaceutical products for renal care. They focus on developing non-absorbed polymeric phosphate and potassium binder compounds to treat …See details»
Ilypsa Company Profile 2024: Valuation, Investors, Acquisition
Ilypsa General Information Description. Developer of renal care pharmaceutical products designed to treat complications of kidney diseases. The company's activities are engaged in …See details»
Ilypsa Inc - Company Profile and News - Bloomberg Markets
Company profile page for Ilypsa Inc including stock price, company news, executives, board members, and contact informationSee details»
Ilypsa , Inc.: Contact Details and Business Profile - RocketReach
Ilypsa , Inc. is a Pharmaceuticals, Biotechnology, and Drug Discovery company located in Santa Clara, California with $7.40 Million in revenue and 37 employees. Find top employees, contact …See details»
Ilypsa - Overview, News & Similar companies | ZoomInfo.com
View Ilypsa (www.ilypsa.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Ilypsa - VentureRadar
Ilypsa (acquired by Amgen) is a therapeutics platform spinout of Symx that develops novel polymer-based, orally bioavailable therapies to treat renal failure and metabolic disorders.See details»
Ilypsa - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jul 19, 2005: Series B - Ilypsa . …See details»
Ilypsa - Updates, News, Events, Signals & Triggers - Crunchbase
Ilypsa is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.See details»
Success Story: Ilypsa, Inc. - intralinks
The Ilyspa team manage who had access to what information, and when. Multiple bidders sought access to reams of Ilypsa data, analyzing every aspect of the company’s operations and …See details»
Amgen to Acquire Ilypsa - pharmtech.com
Jun 7, 2007 Thousand Oaks, CA (June 4)-Amgen agreed to acquire Ilypsa (Santa Clara, CA), a private company that develops nonabsorbed drugs for renal disorders, for $420 million.See details»
Ilypsa - USVP/
Ilypsa (acquired by Amgen) is a therapeutics platform spinout of Symx that develops novel polymer-based, orally bioavailable therapies to treat […]See details»
Ilypsa, Inc. - Pharmaceutical Business review
As with any biotech start-up, conducting research requires capital – and that means raising funds. Ilypsa needed a cost-effective, flexible solution to coordinate financing and facilitate due …See details»
Ilypsa Culture - Comparably
Learn about Ilypsa's culture, see what work's like, read reviews, and find job opportunities.See details»
Ilypsa Management Team - CB Insights
Explore {Ilypsa's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Ilypsa Group Definition - Law Insider
Define Ilypsa Group. means Amgen and all of the Subsidiaries of Amgen, including Ilypsa.See details»
Ily Company Profile -Sales, Contacts, Competitors – Buzzfile
Ily is in the Spas industry within the Amusement and Recreation Services sector and has been in business for approximately 4 years.See details»
Ilyssa - Name Meaning and Origin
The name Ilyssa is a variant of the name Alyssa, which is derived from the Greek name Alyssos. It is believed to have originated from the word "alyssum," which refers to a type of flower. The …See details»